Thomas Mark

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Università Cattolica del Sacro Cuore(Current)

Probity Medical Research

Leo Pharma (Denmark)

Thomas Mark is an author at Università Cattolica del Sacro Cuore specializing in severity index measurement, inflammatory skin diseases, and atopic dermatitis pharmacotherapy.

ORCID

Publications per year

2022–2023

Publications

Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis

Jonathan I. Silverberg, David N. Adam, Matthew Zirwas et al. · American Journal of Clinical Dermatology · 2022 · 51 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +17

Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials

Eric L. Simpson, Andrew Pink, Andrew Blauvelt et al. · American Journal of Clinical Dermatology · 2023 · 29 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

1–2 of 2